ARCHIVES

Science Agencies Seek To Measure Effect Of Research Funding

This article is from The Cancer Letter archive.

Vol. 36 No. 21 | June 4, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

House, Senate Meet On Appropriations Bill Differences

October 6, 1989

New NCI Shakeup: O’Connor Leave DCCP to return To International Office; Adamson Acting Director

September 12, 1980